References
1a
Vacca JP.
Condra JH.
Drug Discovery Today
1997,
2:
261
1b
Steele FR.
Nature Med.
1996,
2:
257
2
Wlodawer A.
Vondrasek J.
Annu. Rev. Biophys. Biomol. Struct.
1998,
27:
249
3
Babine RE.
Bender SL.
Chem. Rev.
1997,
97:
1359
4
Tomasselli AG.
Heinrikson RL.
Biochim. Biophys.
Acta
2000,
189
5 For comparative quantitative structure-activity
relationship studies on anti-HIV drugs, see: Garg R.
Gupta SP.
Gao H.
Babu MS.
Debnath AK.
Hansch C.
Chem. Rev.
1999,
99:
3525
6
Lyle TA.
Wiscount CM.
Guare JP.
Thompson WJ.
Anderson PS.
Darke PL.
Zugay JA.
Emini EA.
Schleif WA.
Quintero JC.
Dixion RAF.
Sigal IS.
Huff JR.
J.
Med. Chem.
1991,
34:
1228
7
Panchagnula R.
Thomas NS.
Int. J. Pharm.
2000,
201:
131
For the synthesis of analogues of
L-685,434, see:
8a
Litera J.
Budesinsky M.
Urban J.
Soucek M.
Collect. Czech. Chem. Commun.
1998,
63:
231
8b
Litera J.
Weber J.
Krizova I.
Pichova I.
Konvaluka J.
Fusek M.
Soucek M.
Collect.
Czech. Chem. Commun.
1998,
63:
541
8c
Evans BE.
Rittle KE.
Homnick CF.
Springer JP.
Hirshfield J.
Veber DF.
J.
Org. Chem.
1985,
50:
4615
9a
cis-Lactone 11 is
also an important intermediate for the synthesis of potent HIV-1
protease inhibitors: Ghosh AK.
McKee SP.
Thompson WJ.
Darke PL.
Zugay JC.
J. Org. Chem.
1993,
58:
1025
9b
Thompson WJ.
Fitzgerald PMD.
Holloway MK.
Emini EA.
Darke PL.
McKeever BM.
Schleif WA.
Quintero JC.
Zugay JA.
Tucker TJ.
Schwering JE.
Homnick CF.
Nunberg J.
Springer JP.
Huff JR.
J. Med. Chem.
1992,
35:
1685
10 For synthesis of analogues of L-682,679,
see: deSolms SJ.
Giuliani EA.
Guare JP.
Vacca JP.
Sanders WM.
Graham SL.
Wiggins JM.
Darke PL.
Sigal IS.
Zugay JA.
Emini EA.
Schleif WA.
Quintero JC.
Anderson PS.
Huff JR.
J.
Med. Chem.
1991,
34:
2852
11
Evans J.
Chem.
Brit.
2001,
April:
47
12
Pesti JA.
Chorvat RJ.
Huhn GF.
Chem. Innovation
2000,
October:
29
13
de Clerq E.
Pure
Appl. Chem.
2001,
73:
55
14
Ghosh AK.
Shin D.
Mathivanan P.
Chem.
Commun.
1999,
1025
15
Li YM.
Xu M.
Lai MT.
Huang Q.
Castro JL.
DiMuzio-Mower J.
Harrison T.
Lellis C.
Nadin A.
Neduvelil JG.
Register RB.
Sardana MK.
Shearman MS.
Smith AL.
Shi XP.
Yin KC.
Shafer JA.
Gardell SJ.
Nature (London)
2000,
405:
689
16
Li YM.
Lai MT.
Xu M.
Huang Q.
DiMuzio-Mower J.
Sardana MK.
Shi XP.
Yin KC.
Shafer JA.
Gardell SJ.
Proc. Natl. Acad.
Sci. U.S.A.
2000,
97:
6138
17
Shearman MS.
Beher D.
Clarke EE.
Lewis HD.
Harrison T.
Hunt P.
Nadin A.
Smith AL.
Stevenson G.
Castro JL.
Biochemistry
2000,
39:
8698
18
Nadin A.
López JMS.
Neduvelil JG.
Thomas SR.
Tetrahedron
2001,
57:
1861
19
Dias LC.
Giacomini R.
J. Braz. Chem. Soc.
1998,
9:
357
20
Dias LC.
Giacomini R.
Tetrahedron Lett.
1998,
39:
5343
21
Dias LC.
Meira PRR.
Ferreira E.
Org. Lett.
1999,
1:
1335
22
Dias LC.
Meira PRR.
Synlett
2000,
37
23
Dias LC.
Ferreira E.
Tetrahedron Lett.
2001,
42:
7159
24a
Fehrentz JA.
Castro B.
Synthesis
1983,
676
24b
Saari WS.
Fisher TE.
Synthesis
1990,
453
For optical stability studies of N-protected α-amino aldehydes,
see:
25a
Jurczak J.
Golebiowski A.
Chem. Rev.
1989,
89:
149
25b
Myers AG.
Zhong BY.
Movassaghi M.
Kung DW.
Lanman BA.
Kwon S.
Tetrahedron Lett.
2000,
41:
1359
26
Benedetti F.
Miertus S.
Norbedo S.
Tossi A.
Zlatoidzky P.
J.
Org. Chem.
1997,
62:
9348
27a
D’Aniello F.
Mann A.
Mattii D.
Taddei M.
J.
Org. Chem.
1994,
59:
3762
27b
Ciapetti P.
Falorni M.
Taddei M.
Tetrahedron
1996,
52:
7379
28
Ley SV.
Norman J.
Griffith WP.
Marsden SP.
Synthesis
1994,
639
For other synthesis of these lactones,
see:
29a
Ghosh AK.
Fidanze S.
J. Org.
Chem.
1998,
63:
6146
29b
Pégorier L.
Larchevêque M.
Tetrahedron
Lett.
1995,
36:
2753 ;
see also ref. 9a
30a
Dess DB.
Martin JC.
J.
Am. Chem. Soc.
1991,
113:
7277
30b
Ireland RE.
Liu L.
J. Org. Chem.
1993,
58:
2899
31
Hoffman RV.
Maslouch N.
Cervantes-Lee F.
J.
Org. Chem.
2002,
67:
1045
32 New compounds and the additional isolatable
intermediates gave satisfactory 1H and 13C
NMR, IR, HRMS and analytical data. Yields refer to chromatographically
and spectroscopically homogeneous materials.
33
L-685,434(1): N
-[(2
R
)-Hydroxy-(1
S
)-indanyl]-(5
S
)-{[
tert
-butoxycarbonyl]-amino-(4
S
)-hydroxy-6-phenyl-(2
R
)-benzyl}-hexanamide: IR
(KBr) 3447, 3365, 3061, 3022, 2917, 2849, 1665, 1645, 1537, 1392,
1278, 1158, 1058, 899, 862, 733, 703, 649 cm-1. 1H
NMR (500 MHz, DMSO): δ = 1.37 (s, 9 H), 1.80-1.96
(m, 2 H), 2.72-2.95 (m, 6 H), 3.02 (dd, J = 5.1,
16.8 Hz, 1 H), 3.45 (m, 1 H), 3.68 (m, 1 H), 3.81 (m, 1 H), 4.22
(t, J = 4.8 Hz, 1 H), 4.81 (d, J = 9.5 Hz, 1 H), 5.23 (dd, J = 6.1, 8.4 Hz, 1 H), 5.87
(d, J = 8.4 Hz, 1 H), 7.05 (brs,
1 H), 7.05-7.30 (m, 14 H). 13C
NMR (125 MHz, DMSO): δ = 28.5, 37.5, 39.0, 39.1,
39.6, 47.1, 57.4, 57.6, 69.3, 73.1, 79.6, 124.1, 125.1, 126.4, 126.5,
127.0, 128.0, 128.4, 128.5, 129.0, 129.3, 138.4, 139.8, 140.1, 140.3,
156.2, 175.4. TLC: Rf = 0.21 (60% EtOAc:hexanes).
L-682,679(2): {(1
S
)-benzyl-4
R
-[1-((1
S
)-carbamoyl-2-phenyl-ethylcarbamoyl)-(1
S
)-3-methyl-butyl-carbamoyl]-(2
S
)-hydroxy-5-phenyl-pentyl} Carbamic Acid tert
-Butyl Ester: IR
(KBr) 3377, 3341, 3190, 2955, 2924, 2872, 2853, 1667, 1649, 1621,
1531, 1451, 1365, 1273, 1250, 1172, 1080, 743, 698 cm-1. 1H
NMR (500 MHz, DMSO): δ = 0.77 (d, J = 6.4 Hz, 3 H), 0.84 (d, J = 6.4 Hz,
3 H), 1.28
(s, 9 H), 1.20-1.35 (m, 2 H), 1.49 (m, 1 H), 1.60 (m, 2
H), 2.45 (dd, J = 8.2, 13.4
Hz, 1 H), 2.53 (dd, J = 9.5, 13.7
Hz, 1 H), 2.70 (dd, J = 5.0,
13.6 Hz, 1 H), 2.78-2.87 (m, 3 H), 3.00 (dd, J = 5.2, 3.7 Hz, 1 H), 3.51-3.57
(m, 1 H), 4.21 (q, J = 6.7 Hz,
1 H), 4.42 (q, J = 5.5 Hz, 1
H), 4.48 (d, J = 6.1 Hz, 1 H),
6.36 (d, J = 9.0 Hz, 1 H), 7.09
(brs, 1 H), 7.12-7.25 (m, 15 H), 7.34 (brs, 1 H), 7.70
(d, J = 8.0 Hz, 1 H), 7.93 (d, J = 8.0 Hz, 1 H). 13C
NMR (125 MHz, DMSO): δ = 23.1, 24.2, 28.0, 28.4,
35.1, 36.3, 37.7, 38.9, 40.9, 43.7, 51.5, 53.5, 56.5, 69.4, 77.6,
125.9, 126.0, 126.4, 128.1, 128.2, 128.3, 129.1, 129.2, 129.4, 137.9,
139.8, 140.0, 155.5, 171.8, 172.8, 174.7. TLC: Rf = 0.18
(70% EtOAc:hexanes).
L-685,458(3): {(1
S
)-benzyl-(4
R
)-[1-((1
S
)-carbamoyl-2-phenyl-ethylcarbamoyl)-(1
S
)-3-methyl-butyl-carba-moyl]-(2
R
)-hydroxy-5-phenyl-pentyl} Carbamic
Acid tert
-Butyl
Ester: White solid. Mp 212-213 °C. [α]D
25 =
-26.8
(c 0.5, CHCl3). IR (KBr):
3375, 3338, 3197, 2960, 2930, 2872, 2856, 1666, 1647, 16231, 1535,
1451, 13675, 1271, 1251, 1174, 1086, 743, 698 cm-1. 1H
NMR (500 MHz, DMSO): δ = 0.74 (d, J = 6.6 Hz, 3 H), 0.81 (d, J = 6.6 Hz,
3 H), 1.24
(s, 9 H), 1.25-1.40 (m, 2 H), 144-1.70 (m, 3 H), 2.40-3.00
(m, 7 H), 3.42 (m, 2 H), 4.16 (m, 1 H), 4.40 (m,
1 H),
4.70 (brs, 1 H), 6.48 (d, J = 9.0
Hz, 1 H), 7.05-7.27
(m, 17 H), 7.62 (d, J = 8.1 Hz, 1 H), 7.87 (d, J = 7.8 Hz, 1 H). 13C
NMR (125 MHz, DMSO): δ = 23.9, 25.4, 26.1, 30.4, 37.6,
38.0, 39.8, 39.9, 42.8, 46.6, 53.7, 55.8, 58.9, 73.5, 79.7, 127.9,
128.0, 128.6, 130.0, 130.2, 130.4, 131.1, 131.4, 140.0, 142.0, 142.3,
157.4, 174.0, 174.8, 175.2. TLC:
Rf = 0.21
(60% EtOAc:hexanes).